Targeted non-LNP Delivery of RNA Therapeutics

Targeted non-LNP Delivery of RNA Therapeutics

Our mission is to develop innovative RNA therapeutics delivered directly to the respiratory tract, without lipid nanoparticle systems, to improve the lives of patients who suffer from respiratory diseases with high unmet medical need.

Questions?

Contact RIGImmune Inc.

QUICK CONTACT

  • This field is for validation purposes and should be left unchanged.